Top 28 CytomX Therapeutics investors
The most complete profiles first. Showing 28 of 28.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Tim ShannonVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 83 more
Verified email available
Daniel OmsteadVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Rob FaulknerVerified
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareHospitalsGeneticsWomen FoundedPortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
James Flynn
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more
Contact details available
Mark Levin
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceEducationPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Neil Exter
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Adeline Oursler
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Avi Kometz
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Cody Tranbarger
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Gerard van Hamel Platerink
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Jason Akus
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Contact details available
Kelly Moynihan
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Walter Kowtoniuk
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
William Motley
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many CytomX Therapeutics investors are on Angel Roster?
Angel Roster lists 28 CytomX Therapeutics investors. 12 of them (43%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (22), Hedge Funds (10) and Private Equity Firms (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do CytomX Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (9), Series B (5) and Series A (1).
Where are CytomX Therapeutics investors based?
Most are based in the United States (28).
Which companies have CytomX Therapeutics investors backed?
The most-backed portfolio companies among them are Editas Medicine (23), Constellation Pharmaceuticals (23), Global Blood Therapeutics (20), Rhythm Metabolic (20) and Element Science (20).
How do I contact CytomX Therapeutics investors?
Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.